📜 iter-4360dd15-0041.log

21072 bytes

# Iter-0041  mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-26T00:43:52
# focus_node: root :: 找到让人类长生不老的方法

========== TRANSCRIPT ==========
  → call task_view({"max_depth":4})

  → call search_memory({"limit":8,"mission_only":true,"query":"senolytic OSK partial reprogramming direct comparison original study min evidence"})

  → call list_recent({"mission_only":true,"n":8})

【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n► [✓ done       ] root: 找到让人类长生不老的方法\n├─   [✓ done       ] n1: 建立 marker 锚定后的局部交换判定框架   ← 已完成 marker 锚定后的局部交换判定框架:固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口,并在触及 wit\n│  ├─   [✓ done       ] n5: 规范化 witness:固定 μ 锚点并限制一次交换的位置   ← 完成 witness 规范化:确认固定 μ 锚点时必须排除触碰 μ 的交换,并用 greedy witness span 将允许交换压缩到局部窗口内;小规模穷举\n│  │  ├─   [✓ done       ] n9: 证伪一次交换跨越 μ 的规范化可能性   ← 用穷举验证并归纳出结构性事实:任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1,因此在固定 μ 位置的 witness 规范化里,不存在“跨\n│  │  ├─   [✓ done       ] n10: 把单侧交换位置压缩为可判定窗口   ← 证明并穷举验证:对左块 greedy witness 的最左/最右嵌入位置 p1..pk,窗口外相邻交换不会改变最大前缀消耗 k,因此允许交换位置可压缩为 [p\n│  │  └─   [✓ done       ] n11: 沉淀 witness 规范形模板   ← 沉淀出 witness 规范形模板:固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口,并用左块最大前缀消耗 k 作\n│  ├─   [✓ done       ] n6: 建立单侧切分判定接口:把可行性压成存在切分点 k   ← 把固定 μ 锚点后的可行性压成了单侧切分接口:左块只通过最大前缀消耗长度 k 传递,且 k 由 X 决定、与 Y 无关。\n│  ├─   [✓ done       ] n7: 刻画交换不依赖右侧的充分条件   ← 验证了一个可复用充分条件:若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k,则对所有右侧 Y 的可行性判定保持不变;并用穷举检查了 small-case \n│  ├─   [✓ done       ] n8: 沉淀可复用的验证模板与失败边界   ← 找到验证模板的失败边界:任意 witness span 不够,必须用 greedy witness span;给出反例 X=abb, S=ba,窗口外交换仍可改\n│  ├─   [✓ done       ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界   ← 在二元字母表、长度 n<=8 的穷举中,未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例;这给出了多交换局部性边\n│  ├─   [✓ done       ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程   ← 完成了一个可执行的局部交换检查流程:先算 k,再用 greedy witness span 的局部闭包限制候选交换;对二元字母表、|X|<=8、|S|<=8 的\n│  ├─   [✓ done       ] n14: 证伪 greedy witne

【tool:search_memory】
{"ok": true, "results": [{"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425164155000", "preview": "!! 下轮焦点(来自 mission `4360dd15` · Iter-0040)  在同组织同终点框架下,继续找能与 senolytic 或 OSK 直接对照的原始研究,优先补齐最小可比实验规格。"}, {"title": "重编程效应要拆成炎症编辑与增殖激活两条轴", "tags": "lesson principle fact reprogramming wound-healing aging", "mission": "4360dd15", "modified": "20260425034206000", "preview": "评估 partial reprogramming 时,不要把“炎症/应激信号下降”自动等同于“细胞周期被激活”;这两者是可分离的轴,必须分别验证。对再生/抗衰干预而言,先确认它到底是在重置损伤相关状态,还是在真正推动增殖程序。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "摘要不等于证据", "tags": "lesson evidence text-comparison", "mission": "4360dd15", "modified": "20260424230541000", "preview": "遇到勘误或文本差分时,必须回到原始页面/全文做逐词比对,搜索结果只能用于定位,不能代替确认。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "先排除非原始研究", "tags": "lesson evidence-retrieval filtering

【tool:list_recent】
{"ok": true, "items": [{"title": "NEXT_FOCUS", "modified": "20260425164155000", "mission": "4360dd15", "tags": "pinned focus"}, {"title": "单一原始正例不足以升级为普适候选", "modified": "20260425161427000", "mission": "4360dd15", "tags": "principle lesson [[[[Autophagy is a baseline-positive mammalian longevity node]]]] [[[[候选筛选要用“干预 + 终点”双约束检索]]]]"}, {"title": "GOAL", "modified": "20260425160720000", "mission": "4360dd15", "tags": "goal pinned"}, {"title": "终点先行的检索约束", "modified": "20260425154711000", "mission": "4360dd15", "tags": "lesson method endpoint search"}, {"title": "不要把整类机制一刀切地排除", "modified": "20260425153833000", "mission": "4360dd15", "tags": "lesson principle aging triage"}, {"title": "候选筛选要用“干预 + 终点”双约束检索", "modified": "20260425152851000", "mission": "4360dd15", "tags": "lesson method principle aging"}, {"title": "relevance-drifting: 把下一轮硬拉回到:IL-11 抑制是否能在成年哺乳动物中同时改善衰老相关多器官纤维化并带来可测的寿命/健康寿命收益。", "modified": "20260425151756000", "mission": "4360dd15", "tags": "iteration relevance-check drifting"}, {"title": "NEXT_FOCUS-drifted-4360dd15-20260425-231756", "modified": "20260425151756000", "mission": "4360dd15", "tags": "archive focus drift"}]}

  → call pubmed_search({"limit":8,"query":"(OSK OR OSKM OR partial reprogramming) senolytic head-to-head tissue"})

  → call web_search({"limit":8,"query":"OSK senolytic head-to-head tissue original study"})

  → call search_memory({"limit":8,"mission_only":true,"query":"OSK senolytic head-to-head tissue same organ same endpoint"})

【tool:pubmed_search】
{"ok": true, "query": "(OSK OR OSKM OR partial reprogramming) senolytic head-to-head tissue", "results": []}

【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}

【tool:search_memory】
{"ok": true, "results": [{"title": "无 head-to-head 就不要做路线优劣结论", "tags": "lesson principle failure", "mission": "4360dd15", "modified": "20260425022753000", "preview": "比较两条路线时,若跨组织扫描仍只能找到各自正例而找不到同研究、同组织、同读出的直接 head-to-head,就应把结论降级为“比较证据缺失”。没有可比设计时,不能从并列正例推导出路线优劣。"}, {"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425164155000", "preview": "!! 下轮焦点(来自 mission `4360dd15` · Iter-0040)  在同组织同终点框架下,继续找能与 senolytic 或 OSK 直接对照的原始研究,优先补齐最小可比实验规格。"}, {"title": "先锁定勘误页,再做最小差分", "tags": "lesson erratum verification search", "mission": "4360dd15", "modified": "20260424225328000", "preview": "找插入/替换型勘误时,优先从 PMC 全文的“should read/corrected to read”入手,拿到原句与更正句后再做最小对齐,别先从 PubMed 摘要页硬抓。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "先用注册库补关键字段", "tags": "lesson abstract-extraction trial-registry endpoint age", "mission": "4360dd15", "modified": "20260424203004000", "preview": "摘要检索失败时,先用 ClinicalTrials.gov/PMC 锁定年龄判据和主要终点,再回填 PMID。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先抽字段再定规则", "tags": "lesson audit endpoint-extraction synonym-mapp

  → call pubmed_search({"limit":10,"query":"bone (OSK OR OSKM OR partial reprogramming)"})

  → call pubmed_search({"limit":10,"query":"bone senolytic navitoclax ABT-263 aged mice"})

  → call pubmed_search({"limit":10,"query":"retina (OSK OR OSKM OR partial reprogramming) senolytic"})

  → call pubmed_search({"limit":10,"query":"lung (OSK OR OSKM OR partial reprogramming) senolytic"})

【tool:pubmed_search】
{"ok": true, "query": "bone (OSK OR OSKM OR partial reprogramming)", "results": [{"pmid": "41893311", "title": "(1)H NMR-Based Metabolomics in Pediatric Acute Lymphoblastic Leukemia: A Pilot Study of Plasma and Cerebrospinal Fluid Profiles.", "source": "Metabolites", "pubdate": "2026 Feb 28", "authors": ["Serrafi A", "Pupek M", "Lewandowski Ł", "Janicka-Kłos A", "Wasilewski A", "Kasprzak A", "Matera-Witkiewicz A", "Zatoński T"], "url": "https://pubmed.ncbi.nlm.nih.gov/41893311/"}, {"pmid": "41871075", "title": "Refining fibroblast-to-cardiomyocyte transdifferentiation protocols to explore emergent self-organization in cardiac cultures.", "source": "PLoS One", "pubdate": "2026", "authors": ["Turchaninova E", "Robustova S", "Kovalenko S", "Dzhabrailov V", "Dolgodvorova A", "Romanova S", "Zybin D", "Popov M"], "url": "https://pubmed.ncbi.nlm.nih.gov/41871075/"}, {"pmid": "41786976", "title": "Local delivery of OSK factors enables partial cellular reprogramming to mitigate osteoarthritis and cartilage fibrosis.", "source": "Exp Mol Med", "pubdate": "2026 Mar", "authors": ["Liu YW", "Zou JT", "Gong JS", "Jin L", "Cao J", "He ZH", "Qian YX", "Wang X"], "url": "https://pubmed.ncbi.nlm.nih.gov/41786976/"}, {"pmid": "41576733", "title": "A self-adapting DNA-crosslinked hydrogel reprograms macrophage polarization and angiogenesis for synergistic repair of diabetic wounds.", "source": "Colloids Surf B Biointerfaces", "pubdate": "2026 May", "authors": ["Feng W", "Gao Y", "Peng Z", "Liu H

【tool:pubmed_search】
{"ok": true, "query": "bone senolytic navitoclax ABT-263 aged mice", "results": [{"pmid": "38636998", "title": "[Senolytic effects on dental pulp stem cell's proliferation and differentiation during long-term expansion].", "source": "Zhonghua Kou Qiang Yi Xue Za Zhi", "pubdate": "2024 May 9", "authors": ["Wang GY", "Liao L", "Tian WD"], "url": "https://pubmed.ncbi.nlm.nih.gov/38636998/"}, {"pmid": "32509782", "title": "The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice.", "source": "Front Cell Dev Biol", "pubdate": "2020", "authors": ["Sharma AK", "Roberts RL", "Benson RD Jr", "Pierce JL", "Yu K", "Hamrick MW", "McGee-Lawrence ME"], "url": "https://pubmed.ncbi.nlm.nih.gov/32509782/"}, {"pmid": "32332723", "title": "Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity.", "source": "Nat Commun", "pubdate": "2020 Apr 24", "authors": ["He Y", "Zhang X", "Chang J", "Kim HN", "Zhang P", "Wang Y", "Khan S", "Liu X"], "url": "https://pubmed.ncbi.nlm.nih.gov/32332723/"}, {"pmid": "26657143", "title": "Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.", "source": "Nat Med", "pubdate": "2016 Jan", "authors": ["Chang J", "Wang Y", "Shao L", "Laberge RM", "Demaria M", "Campisi J", "Janakiraman K", "Sharpless NE"], "url": "https://pubmed.ncbi.nlm.nih.gov/26657143/"}]}

【tool:pubmed_search】
{"ok": true, "query": "retina (OSK OR OSKM OR partial reprogramming) senolytic", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "lung (OSK OR OSKM OR partial reprogramming) senolytic", "results": []}

  → call task_add({"parent_id":"root","rationale":"皮肤之外,骨组织同时出现了 OSK 与 senolytic 的各自原始正例,值得单独核验是否存在同组织同终点直接比较,以避免只靠并列正例下结论。","title":"横向核验骨组织中 OSK vs senolytic 是否存在直接 head-to-head 原始证据"})

  → call search_memory({"limit":6,"mission_only":true,"query":"bone OSK navitoclax ABT-263 head-to-head same tissue same endpoint"})

【tool:task_add】
{"ok": true, "id": "n143", "parent": "root", "title": "横向核验骨组织中 OSK vs senolytic 是否存在直接 head-to-head 原始证据", "status": "pending"}

【tool:search_memory】
{"ok": true, "results": [{"title": "无 head-to-head 就不要做路线优劣结论", "tags": "lesson principle failure", "mission": "4360dd15", "modified": "20260425022753000", "preview": "比较两条路线时,若跨组织扫描仍只能找到各自正例而找不到同研究、同组织、同读出的直接 head-to-head,就应把结论降级为“比较证据缺失”。没有可比设计时,不能从并列正例推导出路线优劣。"}, {"title": "先锁定勘误页,再做最小差分", "tags": "lesson erratum verification search", "mission": "4360dd15", "modified": "20260424225328000", "preview": "找插入/替换型勘误时,优先从 PMC 全文的“should read/corrected to read”入手,拿到原句与更正句后再做最小对齐,别先从 PubMed 摘要页硬抓。"}, {"title": "先用注册库补关键字段", "tags": "lesson abstract-extraction trial-registry endpoint age", "mission": "4360dd15", "modified": "20260424203004000", "preview": "摘要检索失败时,先用 ClinicalTrials.gov/PMC 锁定年龄判据和主要终点,再回填 PMID。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先抽字段再定规则", "tags": "lesson audit endpoint-extraction synonym-mapping", "mission": "4360dd15", "modified": "20260424201859000", "preview": "先用少量高质量试验把字段抽全并标准化,再从表格中反推最小判定规则。"}, {"title": "先从参考链锁定单个原始试验", "tags": "lesson evidence-chain clinical-trials endpoint-classification", "mission": "4360dd15", "modified": "20260424210848000", "preview": "面对综述时,先精确抽出 1 个原始人类试验 PMID,再只核实其主要终点。"}]}

  → call pubmed_search({"limit":20,"query":"(bone OR cartilage OR osteoarthritis) (navitoclax OR ABT-263) (OSK OR OSKM OR partial reprogramming)"})

  → call pubmed_search({"limit":20,"query":"(bone OR cartilage OR osteoarthritis) head-to-head senolytic reprogramming"})

  → call pubmed_search({"limit":20,"query":"(\"partial reprogramming\" OR OSK OR OSKM) navitoclax ABT-263 osteoarthritis"})

【tool:pubmed_search】
{"ok": true, "query": "(bone OR cartilage OR osteoarthritis) (navitoclax OR ABT-263) (OSK OR OSKM OR partial reprogramming)", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "(bone OR cartilage OR osteoarthritis) head-to-head senolytic reprogramming", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "(\"partial reprogramming\" OR OSK OR OSKM) navitoclax ABT-263 osteoarthritis", "results": []}

  → call task_focus({"id":"n143"})

【tool:task_focus】
{"ok": true, "focused": "n143", "title": "横向核验骨组织中 OSK vs senolytic 是否存在直接 head-to-head 原始证据", "status": "in_progress", "path": ["找到让人类长生不老的方法", "横向核验骨组织中 OSK vs senolytic 是否存在直接 head-to-head 原始证据"]}

【assistant】
我已经切到骨组织 head-to-head 核验子任务,并在 PubMed 上做了定向检索:  
- `(bone OR cartilage OR osteoarthritis) (navitoclax OR ABT-263) (OSK OR OSKM OR partial reprogramming)` → **无结果**  
- `(bone OR cartilage OR osteoarthritis) head-to-head senolytic reprogramming` → **无结果**  
- `("partial reprogramming" OR OSK OR OSKM) navitoclax ABT-263 osteoarthritis` → **无结果**  

这说明:至少在 PubMed 可检索原始文献层面,骨/软骨/骨关节炎里尚未出现可直接对照的 OSK vs senolytic 头对头设计。接下来我会把这个子任务标记为失败或证据缺失,并决定是否继续向其它组织平移。

  → call task_fail({"id":"n143","reason":"PubMed 定向检索骨/软骨/骨关节炎中 OSK/partial reprogramming 与 navitoclax/ABT-263 的原始 head-to-head 设计均为 0 命中;目前只能确认比较证据缺失,不能确认存在直接对照。"})

【tool:task_fail】
{"ok": true, "id": "n143", "status": "failed", "next_focus": "root"}

【assistant】
本轮证据结果:

- 骨组织相关定向 PubMed 检索没有找到 OSK vs senolytic 的原始直接对照;
- 也没有找到骨/软骨/骨关节炎里把两条路线放进同一研究、同组织、同终点框架的 head-to-head 文献;
- 因此当前最稳妥结论仍是:**比较证据缺失**,不能从并列正例推出路线优劣。

我把骨组织核验这条子任务判为失败,而不是 done,因为它完成的是“排除存在性”而不是“确认存在”。

<NEXT_FOCUS>继续在其他高概率组织中横向扫描 OSK vs senolytic 是否存在同组织同终点原始 head-to-head 设计,优先寻找能补齐最小可比实验规格的证据。</NEXT_FOCUS>本轮完成了骨组织方向的横向核验,结论是:

- PubMed 定向检索 `(bone/cartilage/osteoarthritis) + (OSK/OSKM/partial reprogramming) + (navitoclax/ABT-263/senolytic)` **没有命中可确认的原始 head-to-head 研究**
- 也没有找到把两条路线放在**同组织、同终点、同研究**框架里的直接对照
- 因而当前只能把结论降级为:**比较证据缺失**,不能据此推路线优劣

任务树更新:
- 新增子任务 `n143: 横向核验骨组织中 OSK vs senolytic 是否存在直接 head-to-head 原始证据`
- 已判定为 **failed**,原因是检索零命中,未能确认存在直接对照

<NEXT_FOCUS>继续在其他高概率组织中横向扫描 OSK vs senolytic 是否存在同组织同终点原始 head-to-head 设计,优先补齐最小可比实验规格。</NEXT_FOCUS>

========== REFLECTION ==========
{
  "progress": "本轮把问题收敛到“骨组织中 OSK 与 senolytic 是否存在同组织、同终点的直接原始对照”,目前检索结果仍只支持“比较证据缺失”。",
  "failure": "最大的盲点是仍未拿到真正的 head-to-head 原始研究,且部分 PubMed 命中与目标主题噪音较大,说明检索式还不够收敛。",
  "empirical_actions": "本轮调用了 task_view、list_recent、search_memory、pubmed_search、web_search 和 task_add;PubMed 在骨/视网膜/肺的组合检索中未返回直接对照证据,web_search 因网络不可达失败,最终新增了一个待核验任务 n143。",
  "lesson": {
    "worthy": false,
    "title": "",
    "extends_existing": "",
    "tags": [],
    "text": ""
  },
  "next_focus": "只做一件事:在骨组织里继续追到“同研究、同组织、同终点”的 OSK vs senolytic 原始对照,若找不到就明确降级为比较证据缺失。"
}